Carglumic Acid

FDA Approved: * October 13, 2021
Pharm Company: * NOVITIUM PHARMA
Category: Hyperammonemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Carglumic Acid Overview

Carglumic acid, sold under the brand name Carbaglu among others, is used for the treatment of hyperammonaemia.[1][4][5] Carglumic acid is a carbamoyl phosphate synthetase 1 (CPS 1) activator.[1] The most common adverse effects include vomiting, abdominal pain, pyrexia (fever), and tonsillitis, anemia, diarrhea, ear infection, other infections, nasopharyngitis, decreased hemoglobin levels, and headache.[1] It was a...

Read more Carglumic Acid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Carglumic_acid

Recent Carglumic Acid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Carglumic Acid
  • Tablet: 200mg
  • Tablet, For Suspension: 200mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Carglumic Acid: (1 result)

Sorted by National Drug Code
  • 70954-120 Carglumic Acid 200 mg Oral Tablet, for Suspension by Novitium Pharma LLC

Other drugs which contain Carglumic Acid or a similar ingredient: (1 result)